Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

The most common formulation of birth control pills has been linked to a doubling of relative risk of heart attack and stroke, ...

Endometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...

Endometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...

Reproductive steroids are powerful hormones that play a key role in the growth and development of our bodies, especially during puberty.

Worldwide, 1 in 10 women of reproductive age suffer from a condition known as endometriosis. It’s an illness where tissue ...

With a significant rise in endometriosis cases among women aged 20-40, early intervention and awareness are crucial to reduce ...

Endometriosis affects 1 in 10 women, often leading to pain and infertility. Early intervention is crucial due to rising cases among women aged 20-40. Experts urge lifestyle changes and regular ...

The NHS is offering trans men a fertility treatment that many women are denied due to its cost - forcing them to go private, it has been revealed. Biological females who want to transition are able to ...

Women who have been diagnosed with endometriosis on average earn significantly less than those who are not suffering from the ...

My journey with endometriosis started with severe menstrual cramping ... Later, painful intercourse and infertility emerged as challenges.